|Day Low/High||66.24 / 67.68|
|52 Wk Low/High||52.04 / 77.03|
After CVS released quarterly earnings and the CEO's appearance on 'Mad Money,' let's look at the charts for this health and pharmacy retailer.
CVS Health states that the chain has kept its stores open as an 'essential' retailer through this pandemic.
Disney's trajectory could provide a blueprint for the reopening of travel and leisure -- and how investors react.
The charts of CVS are in good shape, so expect renewed strength in the weeks ahead.
Some businesses offer curbside delivery while others boost online sales -- still some can't escape closings and cut forecasts.
Let's check and see if all their programs and initiatives could help the charts and indicators of CVS.
As I've stated before, I'm looking for names that are 'stupid cheap', and I'm not sure we're there yet.
It's online, off-price, or nothing in the time of the coronavirus.
Here are a number of things that I'm watching now.
With so many consumers preparing for a potential coronavirus outbreak, you might think that owning retail pharmacy stocks makes sense right now.
For reliable income, a portfolio strategy generating monthly payouts, an opportunity in dividend kings, and favorites among taxable bond funds.
KLA Corp. and Target already have triggered entry points, while CVS Health soon could.
Newly confirmed cases of the Covid-19 virus spiked from Hubei Province in China, where the city of Wuhan is located. The number of related deaths increased as well.
You can sell any stock that's up and take that money to the bank and no one will say, "sorry that was made off of euphoria, we can't take it."
We play the game in front of us. We try to excel in the environment provided.
This rally has been industry, not sector led, and it is all based on technology, whether or not market leaders reside within the Tech sector or not.
Teladoc said has been especially in demand this flu season.
RMPIA ended January up 0.8%, but now the damage from the Wuhan virus is weighing on the future.
While both companies appear like winners, WBA should have more to gain because of its discounted price.
The NYSE used to be the center of capitalism, but now it's where actual engineering, not financial engineering, is taking place.
Here's how two big events early this week make me view this name that's one of my favorite undervalued, dividend-paying companies.
The upcoming quarterly report for WBA might be a market mover, but the charts and indicators of CVS show a healthy stock ready to rise.
What I suggest individual investors do is give their portfolios a physical. Like a visit to the doctor.
Let's review 2019 performance of RMPIA in relation to stock indexes and see what's ahead.
This company made headlines in 2019, and I'm betting on it as a great play -- in many senses of the word -- for this new year.
It seemed to happen overnight. People watched. People listened. People cared. About what? Individual stocks.
Wrong valuations -- such as those in Conagra Brands and Rite Aid -- exist, and they can make you money.
There is no doubt in my mind that the firm is executing at a high level.
Now, many Real Money Post Industrial Average stocks should see a boost from the holiday splurge by shoppers.